We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$64.6B
AUM Growth
+$5.95B
Cap. Flow
+$299M
Cap. Flow %
0.46%
Top 10 Hldgs %
11.91%
Holding
4,318
New
702
Increased
1,590
Reduced
1,355
Closed
633

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$653M
2
AMZN icon
Amazon
AMZN
+$602M
3
XOM icon
ExxonMobil
XOM
+$473M
4
TSLA icon
Tesla
TSLA
+$437M
5
SBUX icon
Starbucks
SBUX
+$380M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 17.69%
3 Consumer Discretionary 13.09%
4 Industrials 7.96%
5 Consumer Staples 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVKD icon
3426
Cadrenal Therapeutics
CVKD
$6.67M
$59K ﹤0.01%
+5,273
New +$41.8K
SLND icon
3427
Southland Holdings
SLND
$33.3M
$59K ﹤0.01%
+11,400
New +$65.5K
CNSY
3428
Cerenome, Inc. Common Stock
CNSY
$26.6M
$58K ﹤0.01%
+1,320
New +$52.9K
RPID icon
3429
Rapid Micro Biosystems
RPID
$104M
$58K ﹤0.01%
77,887
+55,500
+248% +$56.8K
SDOT icon
3430
Sadot Group
SDOT
$13.3M
$58K ﹤0.01%
+73
New +$85.3K
BSIN
3431
Big Sky Industrial
BSIN
$62.8M
$58K ﹤0.01%
58,100
+32,400
+126% +$39.5K
VMAR icon
3432
Vision Marine Technologies
VMAR
$4.71M
0
LEJU
3433
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$58K ﹤0.01%
36,099
-10,500
-23% -$14.4K
TBLT
3434
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$57K ﹤0.01%
+5,531
New +$63.3K
TTNP
3435
DELISTED
Titan Pharmaceuticals
TTNP
$56K ﹤0.01%
6,766
-20
-0.3% -$149
WIT icon
3436
Wipro
WIT
$19.7B
$56K ﹤0.01%
+20,200
New +$49K
BBDO icon
3437
Banco Bradesco
BBDO
$34.3B
$55K ﹤0.01%
+17,184
New +$47.5K
ZURA icon
3438
Zura Bio
ZURA
$542M
$55K ﹤0.01%
+11,800
New +$59K
MBIO icon
3439
Mustang Bio
MBIO
$4.36M
$54K ﹤0.01%
794
-90
-10% -$7.14K
NXGL icon
3440
NexGel
NXGL
$3.13M
$54K ﹤0.01%
25,431
+400
+2% +$772
SHPW
3441
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$54K ﹤0.01%
21,443
+1,800
+9% +$4.27K
CBAT icon
3442
CBAK Energy Technology Ltd
CBAT
$53M
$53K ﹤0.01%
+50,300
New +$44.1K
CCM
3443
Concord Medical Services
CCM
$21.5M
$53K ﹤0.01%
4,790
-1,220
-20% -$13.6K
SLS icon
3444
SELLAS Life Sciences
SLS
$2.3B
$53K ﹤0.01%
+50,400
New +$54.5K
TANH icon
3445
Tantech Holdings
TANH
$6.07M
$53K ﹤0.01%
1,103
-113
-9% -$8.82K
EFXT
3446
Enerflex
EFXT
$2.52B
$52K ﹤0.01%
11,200
-55,900
-83% -$243K
INDP icon
3447
Indaptus Therapeutics
INDP
$167M
$52K ﹤0.01%
1,050
+179
+21% +$11.3K
LPCN icon
3448
Lipocine
LPCN
$17.6M
$52K ﹤0.01%
18,797
+3,200
+21% +$8.46K
BEST
3449
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$52K ﹤0.01%
20,400
GIPR icon
3450
Generation Income Properties
GIPR
$775K
$51K ﹤0.01%
+1,287
New +$50.9K

Similar funds

Renaissance Technologies's Q4 2023 Portfolio in Review

As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
  • Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
  • Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
  • Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
  • Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
  • Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.